相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations
Chad A. Hamilton et al.
GYNECOLOGIC ONCOLOGY (2021)
ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
Jamie O. Brett et al.
BREAST CANCER RESEARCH (2021)
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study
Pamela T. Soliman et al.
CLINICAL CANCER RESEARCH (2020)
The application and prospect of CDK4/6 inhibitors in malignant solid tumors
Qi Du et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)
Stephen R. D. Johnston et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Endometrial Cancer
Karen H. Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Current Therapeutic Progress of CDK4/6 Inhibitors in Breast Cancer
Yanmei Wu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
S. -A. Im et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Matthew P. Goetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies
Erik S. Knudsen et al.
TRENDS IN CANCER (2017)
Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium
Teri A. Longacre et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Validation of OncoPanel A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer
Elizabeth P. Garcia et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Targeting CDK4/6 in patients with cancer
Erika Hamilton et al.
CANCER TREATMENT REVIEWS (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Other Solid Tumors
Amita Patnaik et al.
CANCER DISCOVERY (2016)
f Institutional implementation of clinical tumor profiling on an unselected cancer population
Lynette M. Sholl et al.
JCI INSIGHT (2016)
Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
Brian M. Slomovitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Forging a signature of in vivo senescence
Norman E. Sharpless et al.
NATURE REVIEWS CANCER (2015)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Personalized therapy in endometrial cancer: Challenges and opportunities
Shannon N. Westin et al.
CANCER BIOLOGY & THERAPY (2012)
A method for utilizing co-primary efficacy outcome measures to screen regimens for activity in two-stage Phase II clinical trials
Michael W. Sill et al.
CLINICAL TRIALS (2012)
Endometrial Cancer
Kimberly K. Leslie et al.
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2012)
High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
Nikhil Wagle et al.
CANCER DISCOVERY (2012)
Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer
Carol A. Lange et al.
ENDOCRINE-RELATED CANCER (2011)
ER and PI3K Independently Modulate Endocrine Resistance in ER-Positive Breast Cancer
Brian A. Van Tine et al.
CANCER DISCOVERY (2011)
Management of Recurrent Endometrioid Endometrial Carcinoma An overview
F. H. van Wijk et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis
Michelle Reid-Nicholson et al.
MODERN PATHOLOGY (2006)
Oncogenic K-ras stimulates wnt signaling in colon cancer through inhibition of GSK-3β
JN Li et al.
GASTROENTEROLOGY (2005)
The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers - a study of the National Cancer Institute of Canada Clinical Trials Group
BBY Ma et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2004)
Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study
JV Fiorica et al.
GYNECOLOGIC ONCOLOGY (2004)
Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: A gynecologic oncology group study
T Thigpen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: A gynecologic oncology group study
PG Rose et al.
GYNECOLOGIC ONCOLOGY (2000)
分享论文
